Designing the future of digital therapeutics.
UCB Biopharma · Global R&D Strategy
UCB needed a defensible framework to prioritize R&D investment under deep uncertainty about how AI will reshape healthcare. I synthesized 1,200+ academic sources and 30+ executive interviews with patients, physicians, and pharma leaders into 15 critical megatrends, then built four proprietary scenarios on a 2x2 matrix crossing Patient Empowerment with R&D Speed.
The work was extended into a regional intelligence engine for UCB Germany — translating the global megatrends into a structured framework for ongoing local signal monitoring.
A shared strategic vocabulary across R&D, Medical Affairs, and Digital — making it possible to debate digital therapeutics investments against a structured view of the future, not gut feel.